Home Link (JNJ Logo) Change Country Johnson & Johnson Announces Plans to Separate Consumer Health Business Learn More Global Public Health Learn More Johnson & Johnson Launches Network of Global Health Satellite Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats Our Commitment to Global Health Equity A s the world’s largest healthcare company, we are driven to foster better health for more people in more places around the world. While the world has made significant progress in providing improved healthcare, major gaps remain. Exascerbated by the COVID-19 pandemic, bolder, smarter approaches are needed to overcome the drastic inequity in access to care—now more than ever. Through a dedicated global public health (GPH) organization that combines world-class research and development, global strategy and external affairs capabilities, and local implementation and impact teams, we put the world’s most underserved at the heart of everything we do—measuring our success in lives improved. As a team of innovators, we are committed to pioneering and sustainably delivering meaningful and transformational products in areas where we believe we can make a profound difference: from expanding access to care in HIV, Tuberculosis and global mental health to addressing & preventing future pandemics. Working with global and local partners, we ensure the critical solutions necessary are within reach of those who need them to save lives, cure patients and prevent disease. Upholding the rich heritage of Johnson & Johnson, we are taking on the toughest challenges, and, ultimately, we will do our part to close the gap of inequity and pave the way to a healthier future where all people and communities can thrive. How We Deliver Equitable Access to Care Develop Holistic and Impactful Solutions to Ensure Our Transformational Innovations Are Available, Affordable and Accessible Enable, Advance and Unlock Breakthrough Science for Global Health Challenges Focus, Convene and Advocate to Move the World’s Health Forward, Faster Where We Focus HIV HIV Tuberculosis alt Tuberculosis Neglected Tropical Diseases Neglected Tropical Diseases Mental Health Mental Health Ebola Ebola Antimicrobial Resistance Antimicrobial Resistance Featured Efforts That Advance Equitable Access to Care Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19 Learn More LATEST NEWS Johnson & Johnson Earns a Top Spot on the 2021 Access to Medicine Index Johnson & Johnson Earns a Top Spot on the 2021 Access to Medicine Index LATEST NEWS How Rwanda & J&J Are Spearheading Efforts to Tackle Mental Health How Rwanda & J&J Are Spearheading Efforts to Tackle Mental Health OUR COMPANY How the New Horizons Collaborative is Transforming Pediatric HIV in Uganda How the New Horizons Collaborative is Transforming Pediatric HIV in Uganda INNOVATION The Sky’s the Limit: Drones Delivering HIV supplies in Remote Uganda The Sky’s the Limit: Drones Delivering HIV supplies in Remote Uganda Leader Perspectives on Equitable Access Public health in the developing world faces enormous challenges that require unique solutions, and by engaging, enabling and empowering local health care professionals and entrepreneurs in this way, we can advance the research, development and distribution of new medicines and treatments that will make a difference for patients. — Alex Gorsky, Chairman and CEO, Johnson & Johnson Previous Next Social Media Updates .@gatesfoundation announced a $50 million grant to invest in locally-led research programs. Read @NIHDirector Fran… https://t.co/mpfFj5cO5j With mobile testing, health workers in rural Kenya are securing women’s health through early detection of HPV. Lea… https://t.co/nbqHnX8eg5 Ugandan health workers watched their non-Ugandan colleagues flee at the outset of the pandemic, leaving hospitals u… https://t.co/c4J7qb9To4 Follow Us On Twitter News & Press Releases OUR COMPANY November 18, 2021 Johnson & Johnson is Proud to Lead Efforts to Outpace Antimicrobial Resistance INNOVATION July 26, 2021 The Sky’s the Limit: Drones Delivering HIV Supplies in Remote Uganda INNOVATION July 22, 2021 How Drones Are Being Used to Deliver Lifesaving HIV Drugs to Remote Areas of the World PERSONAL STORIES July 19, 2021 "1.5 Million Children Are Living With HIV in Sub-Saharan Africa. I'm One of the Doctors Treating These Young Patients Every Day" OUR COMPANY July 15, 2021 How the New Horizons Collaborative is Transforming Pediatric HIV in Uganda OUR COMPANY July 09, 2021 Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle... INNOVATION June 08, 2021 40 Years Later— What HIV Taught Us About Responding to Infectious Diseases: A Conversation with Dr. Paul Stoffels INNOVATION June 01, 2021 How Johnson & Johnson Has Pioneered in the Battle Against HIV/AIDS OUR COMPANY March 29, 2021 Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the... INNOVATION March 24, 2021 Building Resilient Health Systems Through Further Investments in TB OUR COMPANY March 24, 2021 Johnson & Johnson Announces Five Initiatives to Help Find the ‘Missing Millions’ of Undiagnosed People... INNOVATION March 24, 2021 2 Pandemics, 1 Goal: Meet 4 Innovators with High-Tech Ideas for Fighting Tuberculosis in the Time of COVID-19 INNOVATION March 24, 2021 As 2030 Deadline Looms We Must Accelerate Progress Against TB OUR COMPANY March 17, 2021 Statement on the Interim SAGE Recommendation Supporting the Use of the Johnson & Johnson COVID-19... OUR COMPANY March 12, 2021 Johnson & Johnson Single-Shot COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization OUR COMPANY January 27, 2021 2021 Access to Medicine Index Ranks Johnson & Johnson to Top 3 Companies Advancing Access to Medicines INNOVATION December 11, 2020 Q&A: Investing Now in Preparation for COVID-19's Successor INNOVATION November 01, 2020 Q&A: The Need for Flexibility and Innovation in TB Care—Now More Than Ever LATEST NEWS September 30, 2020 Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global... OUR COMPANY September 23, 2020 Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate OUR COMPANY July 30, 2020 Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-clinical Studies INNOVATION June 17, 2020 Opinion: Why Global Health Security is Every Company's Business LATEST NEWS July 07, 2020 Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the... OUR COMPANY June 10, 2020 Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to... OUR COMPANY April 24, 2020 Statement of Support on Access to New COVID-19 Tools OUR COMPANY March 30, 2020 Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of... Read All News Resources and Additional Information 2020 Health for Humanity Report Learn More Our SDG Commitment Learn More Center for Health Worker Innovation Learn More Our COVID-19 Response Efforts Learn More More from Johnson & Johnson INNOVATION 3 Cutting-Edge Eye Lenses Designed to Help Improve How You See alt 3 Cutting-Edge Eye Lenses Designed to Help Improve How You See INNOVATION Curing Cancer From Within: The Promise of Cell Therapy alt Curing Cancer From Within: The Promise of Cell Therapy INNOVATION The Next Frontier of Prostate Cancer Care The Next Frontier of Prostate Cancer Care QUICK LINKS Latest News Careers Privacy Policy About J&J Media Center Cookie Policy Legal Notice Products Investors Employees Procurement Our Societal Impact Contact Us Credo Integrity Line MORE FROM JOHNSON & JOHNSON Janssen Janssen Pharmaceutical Companies of Johnson & Johnson Johnson & Johnson Medical Devices Companies Johnson & Johnson Medical Devices Companies Reimagining the Way Healthcare Is Delivered Johnson & Johnson Consumer Health Johnson & Johnson Consumer Health Meeting the Personal Care and Wellness Needs of Consumers Worldwide Our Consumer Safety and Care Commitment Our Consumer Safety and Care Commitment Your Safety Is Our Priority Johnson & Johnson Innovation Johnson & Johnson Innovation Advancing New Healthcare Solutions Through Collaboration Johnson & Johnson Our Story Johnson & Johnson Our Story Learn About the Company's Rich Heritage at Our Digital Museum FOLLOW US Facebook facebook Instagram instagram LinkedIn linkedin Twitter twitter YouTube youtube This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information. Do Not Sell My Personal Information All contents © Copyright Johnson & Johnson Services, Inc.1997-2021. All Rights Reserved. This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies. Accept